SARS-CoV-2–specific B cell detection and therapeutic antibody discovery

To help combat the COVID-19 pandemic, comprehensive characterization of humoral and cellular immune responses to SARS-CoV-2 is essential. 

At Miltenyi Biotec, we have developed reliable tools and methods for analyzing and enriching rare populations of SARS-CoV-2-specific B cells. Tune into this webinar to learn how our products and protocols facilitate COVID-19 research and support the discovery and development of therapeutic antibodies against SARS-CoV-2 and other diseases. 

Learning objectives:

• Understand how antigen specific lymphocytes work together against SARS-CoV-2 
• Learn about tools and protocols for monitoring and researching on SARS-CoV-2 specific B cells 
• Get an overview on the generation of monoclonal antibodies from antigen-specific B cells